
Brawn Biotech standalone net profit declines 84.62% in the December 2019 quarter
Sales decline 37.73% to Rs 13.22 crore
Sales decline 37.73% to Rs 13.22 crore
Feb 11 (Reuters) - Brawn Biotech Ltd BRAW.BO :* DEC QUARTER PROFIT 2.6 MILLION RUPEES VERSUS 3.9 MILLION RUPEES YEAR AGO* DEC QUARTER REVENUE FROM OPERATIONS 212.3 MILLION RUPEES VERSUS...
Nov 10 (Reuters) - Brawn Biotech Ltd BRAW.BO :* Sept quarter profit 5.7 million rupees versus 6.4 million rupees year ago* Sept quarter revenue from operations 116 million rupees versus...
May 30 (Reuters) - Brawn Biotech Ltd BRAW.BO* Says recommended a final dividend of INR 1.5 per equity share Source text for Eikon: ID:nBSE36SwZ6 Further company coverage:...
Feb 7 (Reuters) - Brawn Biotech Ltd BRAW.BO * Brawn Biotech Ltd - dec quarter net profit 2.6 million rupees versus profit 2.4 million rupees year ago * Brawn Biotech Ltd - dec quarter net...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.